MRTX-1257

CAT: 0804-HY-114436-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-114436-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].
CAS Number
[2206736-04-9]
Product Name Alternative
Prodigiosine; NSC47147
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MRTX-1257.html
Purity
99.71
Solubility
DMSO : 55 mg/mL (ultrasonic)
Smiles
N#CC[C@@H]1N(C(C=C)=O)CCN(C2=C3C(CN(C4=C5C(C)=CC=CC5=CC=C4)CC3)=NC(OC[C@H]6N(C)CCC6)=N2)C1
Molecular Formula
C33H39N7O2
Molecular Weight
565.71
Precautions
H302, H315, H319, H335
References & Citations
[1]Matthew et al. Structure-Based Drug Discovery of MRTX1257, a Selective, Covalent KRAS G12C Inhibitor with Oral Activity in Animal Models of Cancer.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras

Related Products

CatalogName
HY-145962MRTX-EX185
HY-145962A-01MRTX-EX185 (formic)
HY-R00161A-01Hsa-miR-1257 agomir
HY-RI00161A-01Hsa-miR-1257 antagomir
HY-R00161-01Hsa-miR-1257 mimic
HY-RI00161-01Hsa-miR-1257 inhibitor
HY-162968MRTF-A-IN-1
HY-162969MRTF-A-IN-2
HY-153078-01MRTF/SRF-IN-1
HY-108507-01MRT-10

Alternative Products

CatalogName
BA5768-10MRTX-1257
M28288-01MRTX-1719
T64000MRTX-EX185
7488/10MRTX 849
B8761-5MRTX-1133
110045Hsp-1257
T62960-01(S)-MRTX-1719
A24354-2Navlimetostat (MRTX-1719) 2mg
T25836-01Mr 1257 MS

Popular Products